Abstract:monary disease in patients with cystic fibrosis (CF). This appears to be due to an exaggerated pulmonary inflammatory response, particularly seen with Respiratory Syncytial Virus lowerrespiratory-tract infection (RSV LRTI). In the normal mouse, infection with RSV leads to increased lymphocytes, neutrophils, and inflammatory cytokines recovered from bronchoalveolar lavage and chronic pulmonary inflammatory infiltrates may last up to 154 days after inoculation. In CF mice, clearance of RSV is further impaired and a much exaggerated inflammatory response is seen compared to non CF mice. As observed using in vitro and in vivo models, RSV causes an exaggerated nuclear factor (NF)kappaB activation and subsequent elevated cytokine and chemokine production. NF-kappaB dimers exist as inactive complexes in the cytoplasm of unstimulated cells by virtue of their interaction with inhibitory proteins (IjBs). These inhibitory proteins are phosphorylated by cellular kinase complexes. This seems to be regulated through activation of the IkappaB kinase alpha (IKK-a) in lung tissue. RSV infection activates IKK-a and IKK-b. In the CF human airway gland cells this exaggerated response of NF-KappaB also can be caused by elevated sodium chloride content. Exposure of non-CF cells to hypotonic sodium chloride solution, compared to isotonic or hypertonic sodium chloride solutions, inhibited activated IKK-a and IL-8 levels. While interleukin (IL) 8 (IL8) levels were inhibited by hypotonic saline solution in CF cells, marked inhibition of the IKK-a system did not occur. Abnormally high sodium chloride levels within the lung also act to inactivate human b-defensin-1, a naturally occurring antibiotic, and change the antimicrobial characteristics of epithelial surface fluid. Respiratory viruses also can cause induction of inflammatory cytokines in human bronchial cells by activation of the p38 mitogenactivated protein kinase (MAPK) signaling pathway. RSV infection inhibits granulocyte apoptosis via kinase and NF-kappaB dependent mechanisms. Lastly, in the mouse model, RSV infection increases expression of inducible nitric oxide synthase and nitric oxide production adding to the inflammatory burden. Palivizumab exhibits both neutralizing and fusion inhibitory activity against RSV. This inhibits RSV replication and appears to decrease the severity of LRTI in high risk human populations. When given in a non-CF murine model 24 hours before RSV inoculation, significant decreases in the number of RSV recovered in bronchoalveolar lavage and histopathological inflammatory scores are observed. Airway obstruction, mucus production and airway hyper-responsiveness also are less than in controls. Palivizumab also has been shown to decrease neurogenic RSV induced inflammation even when given 72 hours after virus inoculation in this same model. Further, Piedra and co-workers have demonstrated that a purified fusion protein vaccine can increase RSV neutralizAddress correspondence to: Michael E. Speer, MD, 6621 Fannin Street, WT 6 – 104, Houston, TX 77030, email: mspeer@bcm.tmc.edu 2011 Pediatric Pharmacy Advocacy Group

Research on Near-Field Obstacle Avoidance for Unmanned Surface Vehicle Based on Heading Window

Obstacle Avoidance Strategy with Path-following for USV Based on Obstacle-guidance Model Using 2D-Lidar in Urban River Conditions

Collision Avoidance and Path Point Tracking Control for Underactuated Unmanned Surface Vehicles with Unknown Model Nonlinearity

A Novel Unmanned Surface Vehicle with 2D-3D Fused Perception and Obstacle Avoidance Module

Autonomous Obstacle Avoidance Algorithm for Unmanned Surface Vehicles Based on an Improved Velocity Obstacle Method

USV Application Scenario Expansion Based on Motion Control, Path Following and Velocity Planning

A Hybrid Path Planning Algorithm for Unmanned Surface Vehicles in Complex Environment with Dynamic Obstacles.

An adaptive dynamic window approach for UUV obstacle avoidance planning in 3D environments

Collision Avoidance Algorithm for USV Based on Rolling Obstacle Classification and Fuzzy Rules

Research on Real Time Obstacle Avoidance Method for AUV Based on Combination of ViT-DPFN and MPC

Obstacle avoidance USV in multi-static obstacle environments based on a deep reinforcement learning approach

Optimized Dynamic Collision Avoidance Algorithm for USV Path Planning

Research on the Obstacle Avoidance Strategy for the Wave Glider in the Maritime Environment Containing Dynamic Obstacles Based on the Improved Artificial Potential Field Method

A human-like collision avoidance method for USVs based on deep reinforcement learning and velocity obstacle

Study on Algorithms and Path-Optimization for USV’s Obstacle Avoidance

Research on Path Planning Method of Unmanned Boat Based on Improved DWA Algorithm

A circle grid-based approach for obstacle avoidance motion planning of unmanned surface vehicles

An Obstacle Avoidance Strategy for AUV Based on State-Tracking Collision Detection and Improved Artificial Potential Field

Respiratory syncytial virus pathophysiology and affect of palivizumab in special populations: cystic fibrosis and immunosuppression.

Autonomous Navigation Algorithm for Underactuated Unmanned Surface Vehicle Based on Model Predictive Control

Collision Avoidance Controller for Unmanned Surface Vehicle Based on Improved Cuckoo Search Algorithm